Sugi Predict
/ Targets
/ PAM
Top predicted compounds (top 20 by supporting neighbours, then confidence)
Clinical trials — most relevant to PAM by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| Protective Effects of Propylene Glycol in Daily Acetaminophen Dosing |
PHASE4 | COMPLETED |
| A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty. |
PHASE3 | COMPLETED |
| Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis |
PHASE3 | COMPLETED |
| Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) |
PHASE3 | COMPLETED |
| Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues |
PHASE3 | COMPLETED |
| L-Arginine in Pre-Eclampsia |
PHASE3 | COMPLETED |
| Triptorelin for Ovary Protection in Childhood Onset Lupus |
PHASE2 | COMPLETED |
| Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia |
PHASE1/PHASE2 | RECRUITING |
| A Study to Evaluate the Safety, Tolerability and Efficacy in Patients With Burn(s) |
PHASE1/PHASE2 | NOT_YET_RECRUITING |
| Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer |
PHASE2 | COMPLETED |
| Reduction by Pasireotide of the Effluent Volume in High-output Enterostomy in Patients Refractory to Usual Medical Treatment |
PHASE2 | COMPLETED |
| Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy |
PHASE2 | UNKNOWN |
| Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU |
PHASE2 | COMPLETED |
| Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer |
PHASE2 | COMPLETED |
| Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma |
PHASE2 | COMPLETED |
| The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine |
PHASE1 | WITHDRAWN |
| A Study of [11C]JNJ-42491293, a Possible PET Ligand for the mGlu2 Receptor, in Healthy Adult Volunteers |
PHASE1 | COMPLETED |
| Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH) |
PHASE1 | COMPLETED |
| Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease |
PHASE1 | COMPLETED |
| Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Pamiparib in Participants With Advanced Cancer |
PHASE1 | COMPLETED |
| Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects |
PHASE1 | COMPLETED |
| Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G) |
EARLY_PHASE1 | WITHDRAWN |
| Accuracy of Detection of Methemoglobin With Pulse Oximetry |
nan | COMPLETED |
| Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19) |
nan | RECRUITING |
| The Protrieve PROTECTOR Study |
nan | COMPLETED |
| PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load |
nan | COMPLETED |
| The Recovery in Stroke Using PAP Study |
nan | RECRUITING |
| Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease |
nan | RECRUITING |
| Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions |
nan | RECRUITING |
| Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A |
nan | ACTIVE_NOT_RECRUITING |
Related proteins — ESM-2 sequence neighbours (a PAM binder may also engage these)